Cargando…

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study

BACKGROUND: Microarray gene-profiling of invasive breast cancer has identified different subtypes including luminal A, luminal B, HER2-overexpressing and basal-like groups. Basal-like invasive breast cancer is associated with a worse prognosis. However, the prognosis of basal-like ductal carcinoma i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Wenjing, Jirström, Karin, Johansson, Christine, Amini, Rose-Marie, Blomqvist, Carl, Agbaje, Olorunsola, Wärnberg, Fredrik
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001723/ https://www.ncbi.nlm.nih.gov/pubmed/21118480 http://dx.doi.org/10.1186/1471-2407-10-653

Ejemplares similares

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
por: Zhou, Wenjing, et al.
Publicado: (2013)

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2013)

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
por: Borgquist, Signe, et al.
Publicado: (2015)

Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort
por: Zhou, Wenjing, et al.
Publicado: (2017)

LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target
por: Hagerling, Catharina, et al.
Publicado: (2020)

In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden
por: Agustsson, Arnar S., et al.
Publicado: (2020)

Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
por: Bergholtz, Helga, et al.
Publicado: (2020)

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
por: Fulford, Laura G, et al.
Publicado: (2007)

Breast Cancer with Neoductgenesis: Histopathological Criteria and Its Correlation with Mammographic and Tumour Features
por: Zhou, Wenjing, et al.
Publicado: (2014)

Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
por: Lyu, Su Ir, et al.
Publicado: (2023)

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ
por: Aguiar, Fernando N., et al.
Publicado: (2013)

Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study
por: Rask, Gunilla, et al.
Publicado: (2022)

Delayed Sentinel Lymph Node Dissection in Patients with a Preoperative Diagnosis of Ductal Cancer In Situ by Preoperative Injection with Superparamagnetic Iron Oxide (SPIO) Nanoparticles: The SentiNot Study
por: Karakatsanis, Andreas, et al.
Publicado: (2023)

Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo
por: Wärnberg, Fredrik, et al.
Publicado: (2006)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Ductal Carcinoma In Situ of the Breast
por: Lee, Richard J., et al.
Publicado: (2012)

Breast Ductal Carcinoma In Situ
por: Sacchini, Virgilio, et al.
Publicado: (2012)

Genetic predisposition to ductal carcinoma in situ of the breast
por: Petridis, Christos, et al.
Publicado: (2016)

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence
por: Jirström, K, et al.
Publicado: (2003)

Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy
por: Giannakeas, Vasily, et al.
Publicado: (2018)

Case Report: Mucocele-Like Tumor of the Breast Associated With Ductal Carcinoma In Situ
por: Jiang, Ying, et al.
Publicado: (2022)

Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer
por: Wei, Zhang, et al.
Publicado: (2012)

Prognostic Risk Assessment and Prediction of Radiotherapy Benefit for Women with Ductal Carcinoma In Situ (DCIS) of the Breast, in a Randomized Clinical Trial (SweDCIS)
por: Wärnberg, Fredrik, et al.
Publicado: (2021)

HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells
por: Ewers, Katharina M., et al.
Publicado: (2021)

Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion
por: Fang, Yan, et al.
Publicado: (2016)

Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Hung, Peiyin, et al.
Publicado: (2019)

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
por: Muggerud, Aslaug Aa, et al.
Publicado: (2010)

Imaging of Noncalcified Ductal Carcinoma In Situ
por: Bragg, Ashley, et al.
Publicado: (2021)

Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ
por: de Roos, M A J, et al.
Publicado: (2005)

Tubular Carcinoma of the Breast: Clinicopathologic Features and Survival Outcome Compared with Ductal Carcinoma In Situ
por: Min, Yejin, et al.
Publicado: (2013)

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
por: Ahlin, Cecilia, et al.
Publicado: (2017)

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015)

Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis
por: Zhang, Geng, et al.
Publicado: (2020)

The Clinical Utility of DCISionRT(®) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
por: Shah, Chirag, et al.
Publicado: (2021)

Metastases of basal-like breast invasive ductal carcinoma to the endometrium: A case report and review of the literature
por: Huo, Zhijun, et al.
Publicado: (2015)

Long-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer Surgery
por: Wärnberg, Fredrik, et al.
Publicado: (2019)

Feasibility of dopamine as a vector-valued feedback signal in the basal ganglia
por: Wärnberg, Emil, et al.
Publicado: (2023)

RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Meurs, Claudia J C, et al.
Publicado: (2020)

Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma in situ
por: Zhang, Xu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0m213k1rt8cfca85t5makajnu7